WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. HIV陰性患者における肺非結核性抗酸菌感染症の治療 treatment of nontuberculous mycobacterial infections of the lung in hiv negative patients
2. 成人における非結核性抗酸菌による骨髄炎の治療 treatment of osteomyelitis due to nontuberculous mycobacteria in adults
3. HIV陰性患者における非結核性抗酸菌感染症の概要 overview of nontuberculous mycobacterial infections in hiv negative patients
4. HIV感染患者における非結核性抗酸菌（MACを除く）の概要 overview of nontuberculous mycobacteria excluding mac in hiv infected patients
5. 非結核性抗酸菌の微生物学 microbiology of nontuberculous mycobacteria

Clinical and radiological deterioration due to Mycobacterium szulgai in an asthmatic patient.

Marjani M, Mansouri N, Tabarsi P, Baghaei P, Farnia P, Sheikholslami FM, Mansouri D.SourceClinical Tuberculosis and Epidemiology Research Center, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. marjani@nritld.ac.ir
Journal of infection in developing countries.J Infect Dev Ctries.2012 Jan 12;6(1):89-91.
We report the case of a 23-year-old asthmatic woman who had clinical and radiological deterioration due to Mycobacterium szulgai infection and good response to anti-mycobacterial treatment without any structural abnormalities in previous lung imaging studies. M. szulgai may be considered a pathogen
PMID 22240435

[Treatment of relatively rare species nontuberculous pulmonary mycobacteriosis].

Kurashima A.SourceFukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), Tokyo, Japan. kurashimaa@fukujuji.org
Kekkaku : [Tuberculosis].Kekkaku.2011 Dec;86(12):923-32.
Today, a treatment guide of relatively rare species nontuberculous mycobacteriosis (NTM) is required ever-increasing. Because, new species are discovered continuously with advanced nucleic identification technique and these results entered routine clinical practice. Secondly, under the influence of
PMID 22338346

鈴木洋祐,笹岡彰一,澤田格,林右
2010-10-31
… 稀な抗酸菌であるMycobacterium szulgai（M. … szulgai）感染症の1例を経験した。 … szulgai が同定され、RFP（リファンピシン）、EB（エタンブトール）、CAM（クラリスロマイシン）の3剤による治療に変更した。 …
NAID 120003057448